National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dideoxyadenosine
A synthetic nucleoside analogue of deoxyadenosine and a prodrug of didanosine in which the 3' hydroxyl group on the ribose moiety is replaced by a hydrogen atom. Dideoxyadenosine competitively inhibits adenylyl cyclase, thereby reducing levels of cyclic adenosine monophosphate (cAMP). By inhibiting cAMP-mediated gene activation in tumor cells, this agent may retard tumor cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:ddA
Chemical structure names:
  • 2',3'-Dideoxyadenosine
  • 6-Amino-9-(2''3'-dideoxy-beta-D-glycero-pentofuranosyl)purine



Previous:diazoxide, dichloromethotrexate, diclofenac sodium gel, didanosine, didemnin B
Next:diethyldithiocarbamate, diethylstilbestrol, Difflam, Diflucan, digoxin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov